31![Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France](https://www.pdfsearch.io/img/4d0873d01eb867c8640def4ee9fd7a99.jpg) | Add to Reading ListSource URL: amdapompe.ehclients.comLanguage: English - Date: 2013-05-26 18:38:43
|
---|
32![Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle](https://www.pdfsearch.io/img/3aac06f115d05900ce8b777338d65d42.jpg) | Add to Reading ListSource URL: amdapompe.ehclients.comLanguage: English - Date: 2011-05-07 19:47:12
|
---|
33![QOL SUCRAID® (sacrosidase) oral solution: DESCRIPTION SUCRAID® (sacrosidase) oral solution is an enzyme replacement therapy for the treatment of genetically QOL SUCRAID® (sacrosidase) oral solution: DESCRIPTION SUCRAID® (sacrosidase) oral solution is an enzyme replacement therapy for the treatment of genetically](https://www.pdfsearch.io/img/65617b573f8a5206560727bf2b10192d.jpg) | Add to Reading ListSource URL: www.sucraid.netLanguage: English - Date: 2014-09-05 11:11:51
|
---|
34![SYNAGEVA BIOPHARMA™ HIGHLIGHTS DATA AT THE NASPGHAN MEETING LEXINGTON, Mass., October 11, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare SYNAGEVA BIOPHARMA™ HIGHLIGHTS DATA AT THE NASPGHAN MEETING LEXINGTON, Mass., October 11, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare](https://www.pdfsearch.io/img/1b6460bb2df43d5f5c653ca9ad20154e.jpg) | Add to Reading ListSource URL: www.synageva.comLanguage: English - Date: 2013-10-11 07:24:04
|
---|
35![Department of Human Genetics Division of Medical Genetics www.genetics.emory.edu Fabry Disease: Important Facts for Women Department of Human Genetics Division of Medical Genetics www.genetics.emory.edu Fabry Disease: Important Facts for Women](https://www.pdfsearch.io/img/507fb4e831837b0df5a84f41a91ce873.jpg) | Add to Reading ListSource URL: genetics.emory.eduLanguage: English - Date: 2009-03-30 13:10:53
|
---|
36![06 radar report final 4_21.qxd 06 radar report final 4_21.qxd](https://www.pdfsearch.io/img/e508d7a8c899c1fddc281745b9facce3.jpg) | Add to Reading ListSource URL: www.fabry.orgLanguage: English - Date: 2014-10-07 04:48:15
|
---|
37![ORIGINAL CONTRIBUTION Enzyme Replacement Therapy in Fabry Disease A Randomized Controlled Trial Raphael Schiffmann, MD ORIGINAL CONTRIBUTION Enzyme Replacement Therapy in Fabry Disease A Randomized Controlled Trial Raphael Schiffmann, MD](https://www.pdfsearch.io/img/1aeada968bc766fda8cf5e7ec0c7a6a6.jpg) | Add to Reading ListSource URL: www.fabry.orgLanguage: English - Date: 2014-10-06 21:28:23
|
---|
38![Microsoft PowerPoint[removed]Fabry Registry figure 3.ppt Microsoft PowerPoint[removed]Fabry Registry figure 3.ppt](https://www.pdfsearch.io/img/0c78f7caefdae106856f45b26694e48e.jpg) | Add to Reading ListSource URL: www.fabry.orgLanguage: English - Date: 2014-10-07 11:33:55
|
---|
39![Microsoft PowerPoint - Fabry Registry annual report figures redrawn.ppt Microsoft PowerPoint - Fabry Registry annual report figures redrawn.ppt](https://www.pdfsearch.io/img/5854960c3d3038b23e3f70199a3995ca.jpg) | Add to Reading ListSource URL: www.fabry.orgLanguage: English - Date: 2014-10-07 09:12:32
|
---|
40![FREG-PT ENROLL MED HST CRF-draft.doc FREG-PT ENROLL MED HST CRF-draft.doc](https://www.pdfsearch.io/img/e8e23becaf0a57bf72ea13fb90fa7447.jpg) | Add to Reading ListSource URL: www.fabry.orgLanguage: English - Date: 2014-10-08 20:51:09
|
---|